96 related articles for article (PubMed ID: 3899557)
21. Vasoactive intestinal peptide: expression of the prohormone in bacterial cells.
DeLamarter JF; Buell GN; Kawashima E; Polak JM; Bloom SR
Peptides; 1985; 6 Suppl 1():95-102. PubMed ID: 2995945
[TBL] [Abstract][Full Text] [Related]
22. A cloned frog vasoactive intestinal polypeptide/pituitary adenylate cyclase-activating polypeptide receptor exhibits pharmacological and tissue distribution characteristics of both VPAC1 and VPAC2 receptors in mammals.
Alexandre D; Anouar Y; Jegou S; Fournier A; Vaudry H
Endocrinology; 1999 Mar; 140(3):1285-93. PubMed ID: 10067855
[TBL] [Abstract][Full Text] [Related]
23. Evidence for common precursors but differential processing of VIP and PHM in VIP-producing tumors.
Fahrenkrug J
Peptides; 1985; 6(3):357-61. PubMed ID: 3840886
[TBL] [Abstract][Full Text] [Related]
24. Hormone genes, structure and control of expression.
Philippe J; Morel C
Biomed Biochim Acta; 1990; 49(12):1141-50. PubMed ID: 2097986
[No Abstract] [Full Text] [Related]
25. In situ hybridization reveals VIP precursor mRNA-containing neurons in monkey and rat neocortex.
Benson DL; Isackson PJ; Jones EG
Brain Res Mol Brain Res; 1991 Jan; 9(1-2):169-74. PubMed ID: 1850073
[TBL] [Abstract][Full Text] [Related]
26. Primary structure and characterization of the precursor to human pituitary adenylate cyclase activating polypeptide.
Ohkubo S; Kimura C; Ogi K; Okazaki K; Hosoya M; Onda H; Miyata A; Arimura A; Fujino M
DNA Cell Biol; 1992; 11(1):21-30. PubMed ID: 1739432
[TBL] [Abstract][Full Text] [Related]
27. Peptide contents of neuropeptide Y, vasoactive intestinal polypeptide, and beta-calcitonin gene-related peptide and their messenger ribonucleic acids after dexamethasone treatment in the isolated rat islets of Langerhans.
Jamal H; Jones PM; Byrne J; Suda K; Ghatei MA; Kanse SM; Bloom SR
Endocrinology; 1991 Dec; 129(6):3372-80. PubMed ID: 1954911
[TBL] [Abstract][Full Text] [Related]
28. Structure and expression of the vasoactive intestinal peptide (VIP) gene in a human tumor.
Gozes I; Bodner M; Shani Y; Fridkin M
Peptides; 1986; 7 Suppl 1():1-6. PubMed ID: 3748844
[TBL] [Abstract][Full Text] [Related]
29. Molecular cloning, characterisation and tissues expression analysis of the goose (Anser cygnoides) vasoactive intestinal peptide (VIP) gene.
Liu Y; Wang C; Wang HY; Wu HL; Chen WH; He DQ
Br Poult Sci; 2014; 55(6):720-7. PubMed ID: 25347433
[TBL] [Abstract][Full Text] [Related]
30. Chromosomal assignment of human VIP/PHM-27 gene to 6q26----q27 region by spot blot hybridization and in situ hybridization.
Gotoh E; Yamagami T; Yamamoto H; Okamoto H
Biochem Int; 1988 Sep; 17(3):555-62. PubMed ID: 3202886
[TBL] [Abstract][Full Text] [Related]
31. Human H9 cells proliferation is differently controlled by vasoactive intestinal peptide or peptide histidine methionine: implication of a GTP-insensitive form of VPAC1 receptor.
Goursaud S; Pineau N; Becq-Giraudon L; Gressens P; Muller JM; Janet T
J Neuroimmunol; 2005 Jan; 158(1-2):94-105. PubMed ID: 15589042
[TBL] [Abstract][Full Text] [Related]
32. Detection of vasoactive intestinal peptide-encoding messenger ribonucleic acid in the rat ovaries.
Gozes I; Tsafriri A
Endocrinology; 1986 Dec; 119(6):2606-10. PubMed ID: 3780542
[TBL] [Abstract][Full Text] [Related]
33. Receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide in turkey cerebral cortex: characterization by [125I]-VIP binding and effects on cyclic AMP synthesis.
Zawilska JB; Niewiadomski P; Nowak JZ
Gen Comp Endocrinol; 2004 Jun; 137(2):187-95. PubMed ID: 15158130
[TBL] [Abstract][Full Text] [Related]
34. VIP gene transcription is regulated by far upstream enhancer and repressor elements.
Liu D; Krajniak K; Chun D; Sena M; Casillas R; Lelièvre V; Nguyen T; Bravo D; Colburn S; Waschek JA
Biochem Biophys Res Commun; 2001 Jun; 284(1):211-8. PubMed ID: 11374892
[TBL] [Abstract][Full Text] [Related]
35. Effects of porcine intestinal heptacosapeptide and vasoactive intestinal polypeptide on insulin and glucagon secretion in rats.
Szecówka J; Lins PE; Tatemoto K; Efendić S
Endocrinology; 1983 Apr; 112(4):1469-73. PubMed ID: 6339205
[TBL] [Abstract][Full Text] [Related]
36. Stimulation by peptide histidine methionine (PHM) of adrenocorticotropin secretion in patients with Cushing's disease: a comparison with the effect of vasoactive intestinal peptide (VIP) and a study on the effect of combined administration of corticotropin-releasing hormone with PHM or VIP.
Watanobe H; Tamura T
J Clin Endocrinol Metab; 1994 Jun; 78(6):1372-7. PubMed ID: 8200939
[TBL] [Abstract][Full Text] [Related]
37. [Elucidation of biosynthetic process and regulation mechanism of bioactive peptides and their receptors].
Itoh N
Yakugaku Zasshi; 1992 Jul; 112(7):419-31. PubMed ID: 1432595
[TBL] [Abstract][Full Text] [Related]
38. Biosynthesis and Function of VIP and Oxytocin: Mechanisms of C-terminal Amidation, Oxytocin Secretion and Transport.
Yonekura H; Kato I; Yamamoto Y; Ikeda T; Higashida H; Okamoto H
Endocrinology; 2023 Aug; 164(9):. PubMed ID: 37548257
[TBL] [Abstract][Full Text] [Related]
39. High conservation of upstream regulatory sequences on the human and mouse vasoactive intestinal peptide (VIP) genes.
Sena M; Bravo DT; Von Agoston D; Waschek JA
DNA Seq; 1994; 5(1):25-9. PubMed ID: 7894056
[TBL] [Abstract][Full Text] [Related]
40. The secretin precursor gene. Structure of the coding region and expression in the brain.
Itoh N; Furuya T; Ozaki K; Ohta M; Kawasaki T
J Biol Chem; 1991 Jul; 266(19):12595-8. PubMed ID: 2061329
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
